FDA.reportPublic FDA data

Application 020250

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HALFANHALOFANTRINE HYDROCHLORIDETABLET;ORAL250MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
34431SUPPL2002-08-01
24659SUPPL2002-08-01
12374SUPPL2002-08-01
2245SUPPL2002-08-01